Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: Nat Rev Nephrol. 2010 Dec 14;7(2):85–95. doi: 10.1038/nrneph.2010.171

Table 2.

Glomerular lesions caused by cancer treatments

Glomerular lesions Cancer treatment agents
Thrombotic microangiopathy Mitomycin C, gemcitabine, anti-VEGF agents
Collapsing focal segmental glomerulosclerosis Pamidronate
Focal segmental glomerulosclerosis Interferon α